KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Accured Expenses (2016 - 2026)

Medtronic's Change in Accured Expenses history spans 13 years, with the latest figure at $703.0 million for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 27.82% year-over-year to $703.0 million; the TTM value through Jan 2026 reached $289.0 million, down 40.66%, while the annual FY2025 figure was $209.0 million, 46.55% down from the prior year.
  • Change in Accured Expenses for Q1 2026 was $703.0 million at Medtronic, up from -$182.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $703.0 million in Q1 2026 and bottomed at -$673.0 million in Q3 2023.
  • The 5-year median for Change in Accured Expenses is $177.0 million (2023), against an average of $110.5 million.
  • The largest annual shift saw Change in Accured Expenses surged 10250.0% in 2022 before it crashed 357.82% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $133.0 million in 2022, then tumbled by 119.55% to -$26.0 million in 2023, then tumbled by 296.15% to -$103.0 million in 2024, then plummeted by 76.7% to -$182.0 million in 2025, then surged by 486.26% to $703.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Change in Accured Expenses are $703.0 million (Q1 2026), -$182.0 million (Q4 2025), and -$598.0 million (Q3 2025).